Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowGreenwood-based Elona Biotechnologies said it has created two subsidiaries to boost its biosimilar/biogeneric/follow-on
protein business.
R&D Enterprises will develop and commercialize technology. Zimmerman Biotechnologies LLC
will make protein products.
Elona develops and produces human insulin, insulin analogs, human growth hormone and
other proteins to treat disease.
"We now have the ability to go all the way from the gene through a formulated
drug product," said Ron Zimmerman, founder and president of Elona.
Elona last year was named by the Indiana
Economic Development Corp. as one of 50 "Companies to Watch."
The new subsidiaries "will focus
our efforts to meet the surge in demand for our services as world markets demand biogeneric protein products," Zimmerman
added.
Please enable JavaScript to view this content.
